An investigative review by Swedish Radio revealed that doctors working for Kry — one of Scandinavia’s largest digital healthcare platforms — were sometimes seeing extremely high daily volumes of patients, with some clinicians reporting up to 100 online consultations in a single day. The reporting said the company ranked clinicians by speed and offered bonuses tied to higher patient throughput. Kry’s leadership responded that the firm does not reward speed at the expense of clinical quality and that it operates extensive quality controls.
That story touched a raw nerve across Nordic healthcare systems that combine publicly funded services with private digital providers: when telemedicine platforms turn patient encounters into measurable throughput, how do we ensure that incentives do not erode clinical standards, continuity of care or public trust?
Where the market stands in 2026
Telemedicine has matured since the pandemic catalysed rapid adoption. Digital-first providers are now an established part of primary care in Sweden, Norway, Denmark and Finland, offering convenience and faster access while competing for contracts and patients. Several structural shifts are relevant:
- Reimbursement models: Nordic payers have experimented with activity-based fees, capitated contracts and blended payments. Where payments are tied to consultations, platforms naturally optimise throughput.
- Data and AI: More platforms use automated triage, AI symptom checkers and decision support. These tools increase efficiency but also create new safety and regulatory challenges.
- Regulatory scrutiny and transparency demands: Governments and medical regulators have raised expectations for quality reporting, continuity metrics and audit trails for teleconsultations. Public debate about platform incentives has made transparency a reputational imperative.
- Workforce pressure: A constrained primary-care workforce creates incentives to maximise remote throughput while maintaining access.
Why incentive design matters
Economic and behavioural realities explain how a per-visit, speed-focused incentive structure can lead to risk:
- Time-quality trade-offs: Shorter consultations reduce opportunity to take comprehensive histories, explore differential diagnoses, or address multimorbidity and psychosocial issues — common in primary care.
- Defensive overuse or underuse: To meet volume targets, clinicians may default to quick fixes, repeat prescriptions or unnecessary testing ordered without adequate evaluation. Conversely, complex cases may be referred back to public care, shifting costs and risks.
- Fragmentation and continuity loss: Digital platforms often provide episodic care. High-volume throughput exacerbates discontinuity: no longitudinal patient record, less follow-up, weaker therapeutic relationships.
- Professional strain: Clinicians report moral distress when organisational KPIs conflict with clinical judgement, potentially increasing burnout and staff turnover.
Evidence and metrics to watch
Policymakers and payers should demand and monitor outcome-oriented metrics, not just activity counts. Useful indicators include:
- Clinical outcomes: resolution rates, follow-up visit rates, referral patterns to higher-acuity care, adverse events.
- Prescribing patterns: antibiotic and psychotropic prescribing rates compared with in-person norms and evidence-based guidelines.
- Patient-reported outcomes and satisfaction: beyond access times, measure perceived quality, understanding of diagnosis and adherence.
- Continuity and data integration: proportion of consultations recorded in national EHRs; frequency with which digital visits lead to in-person follow-up within the same care pathway.
- Audit sampling: peer review of recorded consultations, including random audits and targeted reviews for high-volume clinicians.
Business implications for digital providers
Digital-first firms seeking scale must reconcile three objectives: faster access, quality of care and sustainable clinician employment models. Practical steps companies can take:
- Align pay with outcomes: replace pure volume bonuses with blended incentives tied to quality, patient satisfaction and appropriate use.
- Set safety thresholds: minimum recommended consultation times for certain complaint categories, escalation triggers, and clinical decision-support nudges.
- Invest in continuous medical education and supervision: regular case reviews, peer feedback loops and opportunities for clinicians to flag concerns about workload or algorithms.
- Integrate with national health records: reduce fragmentation and create clinical continuity that benefits patient safety and system costs.
Regulatory and payer actions
Public payers and regulators have levers to reshape incentives:
- Contract design: favour bundled or capitation elements that reward prevention and appropriate referrals over raw visit volumes.
- Mandatory transparency: require platforms to publish anonymised quality indicators, prescribing patterns and wait times.
- Professional standards: national medical boards should clarify how digital KPIs fit into clinical responsibility and provide guidance on acceptable consultation volumes and durations.
- Technology assessment: regulators should examine how AI triage tools affect clinical throughput and outcomes, and require evidence of safety and effectiveness.
A path forward: balancing access and quality
Digital platforms deliver undeniable benefits: fast access, convenience and sometimes lower system costs. But access alone isn’t a sufficient metric of success. Nordic health systems must design incentives and oversight that preserve clinical judgement and continuity while harnessing efficiency gains. That will require coordinated action from platforms, payers, regulators and clinicians.
Practical checklist for stakeholders
- For platforms: audit clinician workloads, remove perverse bonuses, tie compensation to quality metrics.
- For clinicians: document decisions, escalate complex cases, push for peer review and transparency.
- For payers: pilot blended payment models that reward appropriate outcomes and integrated care.
- For regulators: mandate quality reporting and define professional responsibilities in telemedicine.
The Swedish Radio investigation highlighted a core tension of modern healthcare: metrics that drive growth can, if poorly designed, degrade the very outcomes they intend to improve. The future of Nordic digital care will depend on aligning incentives with patient-centred outcomes, strengthening oversight, and integrating digital services into the broader health ecosystem. That is both a regulatory challenge and a commercial opportunity for platforms that can prove better-quality, integrated care — not just faster care.
Next in this series
Our next article will analyse how Nordic regulators and public payers have adjusted reimbursement and oversight since the early telemedicine boom — comparing Sweden, Norway, Denmark and Finland for policy lessons and market impacts. If you would like us to investigate specific providers, contractual models or patient outcomes, tell us which topic matters most to you.
Connect with us:
- Nordic Business Journal — editorial@nordicbusinessjournal.com
- LinkedIn: Nordic Business Journal | Twitter: @NordicBizJnl